95.23 - 97.14
55.47 - 103.81
1.63M / 1.80M (Avg.)
55.57 | 1.74
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-6.48%
Negative revenue growth while FSM stands at 15.36%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-16.49%
Negative gross profit growth while FSM is at 50.62%. Joel Greenblatt would examine cost competitiveness or demand decline.
-22.71%
Negative EBIT growth while FSM is at 129.50%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-22.71%
Negative operating income growth while FSM is at 129.50%. Joel Greenblatt would press for urgent turnaround measures.
124.21%
Net income growth comparable to FSM's 114.91%. Walter Schloss might see both following similar market or cost trajectories.
123.81%
EPS growth similar to FSM's 115.38%. Walter Schloss would assume both have parallel share structures and profit trends.
123.81%
Similar diluted EPS growth to FSM's 115.38%. Walter Schloss might see standard sector or cyclical influences on both firms.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Dividend reduction while FSM stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
-14.72%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
114.79%
Positive FCF growth while FSM is negative. John Neff would see a strong competitive edge in net cash generation.
233.81%
10Y revenue/share CAGR under 50% of FSM's 30387.44%. Michael Burry would suspect a lasting competitive disadvantage.
3.82%
5Y revenue/share CAGR under 50% of FSM's 86.78%. Michael Burry would suspect a significant competitive gap or product weakness.
-19.84%
Negative 3Y CAGR while FSM stands at 1.60%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
275.60%
10Y OCF/share CAGR above 1.5x FSM's 42.25%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
-21.68%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
-39.59%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
36.10%
Below 50% of FSM's 135.57%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
-70.63%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
-72.98%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
379.39%
10Y equity/share CAGR above 1.5x FSM's 141.89%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
52.05%
5Y equity/share CAGR above 1.5x FSM's 21.28%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
13.33%
Positive short-term equity growth while FSM is negative. John Neff sees a strong advantage in near-term net worth buildup.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Negative 5Y dividend/share CAGR while FSM stands at 0.00%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
No Data
No Data available this quarter, please select a different quarter.
64.29%
AR growth is negative/stable vs. FSM's 208.83%, indicating tighter credit discipline. David Dodd confirms it doesn't hamper actual sales.
No Data
No Data available this quarter, please select a different quarter.
-1.23%
Negative asset growth while FSM invests at 3.30%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
0.14%
Under 50% of FSM's 1.32%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
-6.48%
We’re deleveraging while FSM stands at 2.70%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
15.62%
SG&A declining or stable vs. FSM's 186.22%. David Dodd sees better overhead efficiency if it doesn't hamper revenue.